National Geographic recently looked at potential locations around the world where cannabis tourism could flourish.
With the recent, so-called decline of the Netherlands as the most popular destination for cannabis tourism for the past 40 years, National Geographic explored the many global locations that could rise to become destinations for foreign visitors to consume cannabis (1). The locations included Thailand, Germany, and South Africa, plus certain countries and states in the Americas. Annually, the global cannabis tourism industry is estimated to be $17 billion (1).
The Netherlands decriminalized cannabis in 1976, and in May 2023, bans on public cannabis smoking began in Amsterdam as part of a response to complaints from residents about misbehaving tourists (1,2). The fine for public smoking is $107 (1).
In June 2022, Thailand removed cannabis flower from the list of prohibited substances, and an estimated 12,000 dispensaries appeared within a year (3). Over a million residents have registered to cultivate cannabis, but the regulations are still undefined (1,3).
“Thailand is a freewheeling environment at the moment, with very little restriction on consumption by tourists,” said Michael O’Regan, tourism lecturer at Glasgow Caledonian University in Scotland (1). “The country is attracting cannabis tourists across the Asian region and may increasingly attract Europeans.”
Germany is reportedly poised to be the first major European country to enact liberal cannabis legislation (4). Last month, Germany passed legislation that would make possession and consumption of cannabis legal in certain circumstances and would also allow residents to cultivate a limited number of plants (4). However, as O’Regan explained, Germany will likely not encourage cannabis tourism.
“They explicitly point to the Netherlands as a model to be avoided,” he explained (1). “Under the new law, cannabis shall only be available for purchase in limited quantities and for own consumption by persons who are registered in so-called cannabis clubs, which will make purchases difficult for international tourists…I don’t think any city wants to repeat the same experience and have tourists fly from across the region to consume drugs.”
In looking at South Africa, where cannabis use in private spaces has been legal since 2018, tourism and economic opportunities reportedly seem to be growing in part due to hemp products, cannabis tours, and “bud and breakfast” accommodations (1). “South Africa's cannabis tourism is poised to be a major niche tourism segment for the country,” said Tafadzwa Matiza, tourism lecturer at North-West University (1). A bill for full legalization for recreational consumption in the country will potentially be voted on within the next few months (5).
As more states in the US and countries such as Argentina, Brazil, Colombia Costa Rica, Ecuador, Panama, and Peru have been relaxing their cannabis laws, sales and cannabis-themed events and attractions have markedly increased (1). Regardless of the location of cannabis tourism, the takeaway advice was for tourists to be respectful and do their research on the cannabis laws in place anywhere they visit (1).
References
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.